Table 1 Characteristics and results from the Berg Balance Scale (BBS) and the Modified Motor Assessment Scale (M-MAS UAS-95) at baseline
Participants during the period; | |||
|---|---|---|---|
0 to 3 months | 3 to 6 months | 6 to 12 months | |
Characteristics | n=72 | n=71 | n=65 |
Age, years, median (range) | 73 (50–94) | 73 (47–92) | 73 (47–90) |
Patients, n (%) | |||
Female | 33 (46) | 27 (38) | 26 (40) |
Male | 39 (54) | 44 (62) | 39 (60) |
Stroke classification (TOAST), n (%) | |||
Large vessel disease | 17 (24) | 18 (25) | 17 (26) |
Small vessel disease | 21 (29) | 21 (30) | 17 (26) |
Cardioembolic stroke | 15 (21) | 11 (15) | 11 (17) |
Cryptogenic stroke | 13 (18) | 14 (20) | 12 (19) |
Intracerebral haemorrhage | 6 (8) | 7 (10) | 8 (12) |
Side of Lesion-, n (%) | |||
Right side lesion | 35 (49) | 32 (45) | 28 (43) |
Left side lesion | 37 (51) | 39 (55) | 37 (57) |
Hypertension | 47 (65) | 44 (62) | 41 (63) |
Diabetes mellitus | 17 (24) | 18 (25) | 17 (26) |
Results from clinical scales 1–7 days after stroke onset | |||
BBS median (range) (n) | 35 (0–56) (n=71) | 41 (0–56) (n=70) | 41 (0–56) (n=64) |
M-MAS UAS-95 median (range) | 45 (12–55) (n=65) | 47 (12–55) (n=65) | 50 (16–55) (n=59) |